|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Loss on change in fair value of ELOC program | |||||
| Change in fair value of derivative and warrant liability | |||||
| Amortization of debt issuance cost | |||||
| Non-cash lease amortization | |||||
| Loss on disposal of property and equipment | |||||
| Amortization of capitalized commissions | |||||
| Loss on early extinguishment of debt | |||||
| Foreign currency gain/loss from remeasurement | |||||
| Change in fair value of contingent acquisition liabilities | |||||
| Change in fair value of derivative | |||||
| Deferred income taxes | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Contract assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other current liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Other non-current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Capitalized software development costs | |||||
| Payment related to acquisitions, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the issuance of Series A Preferred Stock, net of issuance costs | |||||
| Proceeds from sales of Class A common stock under the ELOC program, net of issuance costs | |||||
| Proceeds from exercise of stock options and employee stock purchase plan | |||||
| Proceeds from warrants exercised | |||||
| Payment of financing costs associated with the Sales Agreement, Equity Distribution Agreement, Execute Equity Distribution Agreement, and Second Equity Distribution Agreement | |||||
| Proceeds from the issuance of debt, net of issuance costs | |||||
| Proceeds from the issuance of common stock | |||||
| Payments on Term Loan and Amelia Debt | |||||
| Payment to settle contingent holdback liabilities from SYNQ3 acquisitions | |||||
| Payments on finance leases | |||||
| Net cash provided by financing activities | |||||
| Effects of exchange rate changes on cash | |||||
| Net change in cash, cash equivalents, and restricted cash equivalents | |||||
| Cash, cash equivalents, and restricted cash equivalents, beginning of year | |||||
| Cash, cash equivalents, and restricted cash equivalents, end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
| Noncash investing and financing activities: | |||||
| Conversion of Series A Preferred Stock to Class A common stock | |||||
| Convertible preferred stock | |||||
| Redeemable convertible preferred stock | |||||
| Total conversion of Series A Preferred Stock to Class A common stock | |||||
| Issuance of Class A Common Stock to settle commitment shares related to the ELOC program | |||||
| Settle Commitment Shares Related to the ELOC Program | |||||
| Settle Obligations Under Amelia Debt | |||||
| Settle Contigent Holdback Consideration Of SYNQ3 Acquisition Member | |||||
| Total issuance of Class A Common Stock to settle commitment shares related to the ELOC program | |||||
| Issuance of Class A Common Stock to settle obligations under Amelia Debt | |||||
| Issuance of Class A Common Stock to settle contingent holdback consideration of SYNQ3 acquisition | |||||
| Total issuance of Class A Common Stock to settle contingent holdback consideration of SYNQ3 acquisition | |||||
| Conversion of convertible note into common stock pursuant to Business Combination | |||||
| Deferred offering costs reclassified to additional paid-in capital | |||||
| Purchases of property and equipment under accrued liabilities | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
| Debt discount through issuance of common stock warrants | |||||
| Fair value of Class A common stock and deferred equity consideration issued to acquire SYNQ3 and Amelia | |||||
| Fair value of contingent earnout and holdback consideration under acquisitions | |||||
| Fair value of deferred cash consideration under acquisition | |||||
| Other Acquisition | |||||
| Interactions Acquisition | |||||
| Stock-based compensation included in capitalized software development costs | |||||
| Reconciliation to amounts on the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Current portion of restricted cash equivalents | |||||
| Non-current portion of restricted cash equivalents | |||||
Loading...